Waters Corp WAT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Waters Corp (WAT) Business Model and Operations Summary
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
Key Insights
Waters Corp (WAT) Core Market Data and Business Metrics
Latest Closing Price
$356Market Cap
$21.12 BillionPrice-Earnings Ratio
33.24Total Outstanding Shares
59.41 Million SharesTotal Employees
7,600Dividend
No dividendIPO Date
November 17, 1995SIC Description
Laboratory Analytical InstrumentsPrimary Exchange
New York Stock ExchangeHeadquarters
34 Maple St, Milford, MA, 01757
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-144.02 Million |
| Net Cash Flow | $-70.66 Million |
| Exchange Gains/Losses | $7.92 Million |
| Net Cash Flow From Investing Activities | $-144.02 Million |
| Net Cash Flow From Operating Activities, Continuing | $762.12 Million |
| Net Cash Flow, Continuing | $-78.58 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Interest Income/Expense After Provision For Losses | $-71.48 Million |
| Benefits Costs and Expenses | $2.20 Billion |
| Costs And Expenses | $2.13 Billion |
| Net Income/Loss | $637.83 Million |
| Income Tax Expense/Benefit | $117.03 Million |
| Cost Of Revenue | $1.20 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $616.67 Million |
| Comprehensive Income/Loss | $616.67 Million |
| Other Comprehensive Income/Loss | $-21.16 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-21.16 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Inventory | $477.26 Million |
| Equity Attributable To Parent | $1.83 Billion |
| Noncurrent Assets | $2.88 Billion |
| Liabilities | $2.73 Billion |
| Equity | $1.83 Billion |
| Intangible Assets | $567.91 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||